• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

The decision to stop or keep ADHD medication during breastfeeding and pregnancy is a challenge for women suffering from the condition. There isn't much information on how to get medication for adhd uk (Click Link) long-term exposure to these drugs can affect the foetus.

A study recently published in Molecular Psychiatry shows that children exposed to ADHD medication in the uterus do not develop neurological developmental disorders such as hearing or vision impairment seizures, febrile seizures or IQ impairment. The authors acknowledge that more high quality studies are required.

Risk/Benefit Analysis

Pregnant women who take ADHD medications need to balance the advantages of taking them against potential risks to the fetus. Physicians do not have the data needed to make unequivocal recommendations but they can provide information about the risks and benefits to help pregnant women make informed decisions.

A study published in Molecular Psychiatry found that women who used ADHD medications during their early pregnancy did not have an increased risk of fetal cardiac malformations or major birth defects that are structural. Researchers used a vast population-based case-control study to evaluate the incidence of major structural birth defects in infants born to mothers who had taken stimulants during early pregnancy, as well as those who had not. Clinical geneticists, pediatric cardiologists and other experts looked over the cases to confirm that the classification was correct and to minimize any bias.

However, the researchers' study had its limitations. The most important issue was that they were unable to separate the effects of the medication from the disorder at hand. This makes it difficult to determine whether the small differences observed in the groups that were exposed are due to the use of medication or the confounding effect of comorbidities. The researchers also did not study long-term outcomes for the offspring.

The study did find that infants whose mothers took ADHD medication during pregnancy were at a more risk of being admitted to the neonatal intensive care unit (NICU) than those who were born without any medication or had taken off their medication prior to or during pregnancy. The reason for this was central nervous system disorders, and the increased risk for admission was not found to be affected by the type of stimulant medications were taken during pregnancy.

Women who took stimulant ADHD medication during pregnancy also had an increased chance of having a caesarean birth or having a child with a low Apgar score (less than 7). These increases did not appear to be affected by the kind of medication used during pregnancy.

Researchers suggest that the minor risks posed by the use of ADHD medications in early pregnancies may be offset by the more beneficial outcomes for both mother and baby of continuing treatment for the woman’s disorder. Physicians should speak with their patients about this and as much as possible, assist them develop coping strategies that may reduce the impact of her disorder in her daily functioning and her relationships.

Interactions with Medication

As more women than ever before are being diagnosed with ADHD and being treated with medication, the issue of whether to continue or end treatment during pregnancy is a question that doctors are having to confront. Often, these decisions are made in the absence of clear and authoritative evidence either way, so physicians must weigh their knowledge from their own experiences, those of other doctors, and what the research suggests about the subject and their best judgment for each individual patient.

The issue of potential risks for infants can be difficult to determine. Many of the studies on this topic are based on observational data rather than controlled research and their conclusions are often contradictory. Additionally, the majority of studies limit their analysis to live births, which can undervalue the serious teratogenic effects that can lead to abortion or termination of the pregnancy. The study that is discussed in the journal club addresses these shortcomings by analyzing both the data from deceased and live births.

Conclusion: While some studies have found a positive correlation between ADHD medications and certain birth defects, other studies have not found a correlation. Most studies show that there is a neutral, or slightly negative, effect. As a result an accurate risk-benefit analysis must be conducted in every case.

For many women with ADHD, the decision to stop medication is difficult, if not impossible. In a recent article in Archives of Women's Mental Health by psychologist Jennifer Russell, she notes that stopping adhd medication weekends adults common adhd medications uk medications during pregnancy can increase depression and feelings of isolation. Furthermore, a loss of medication can affect the ability to complete jobs and drive safely, which are important aspects of daily life for many people suffering from ADHD.

She suggests that women who are not sure whether to continue taking the medication or stop it due to their pregnancy educate family members, colleagues, and their friends about the condition, the effects on daily functioning, and the benefits of keeping the current treatment regimen. It can also aid in ensuring that the woman feels supported as she struggles with her decision. It is important to note that certain medications are able to pass through the placenta so if a woman decides to discontinue her ADHD medication during pregnancy and breastfeeding, she must be aware that the effects of the drug can be transferred to the child.

Risk of Birth Defects

As the use and abuse of ADHD medications to treat the symptoms of attention deficit hyperactivity disorder (ADHD) is increasing, so does concern about the potential adverse effects of the drugs on foetuses. A study that was published in the journal Molecular Psychiatry adds to the existing knowledge on this subject. Using two massive data sets, researchers were able to look at more than 4.3 million pregnancies and see whether the use of stimulant medications increased the risk of birth defects. Researchers discovered that although the overall risk is low, the first trimester ADHD medication use was associated with slightly higher rates of specific heart defects like ventriculoseptal defect.

The researchers of the study did not discover any connection between the use of early medications and other congenital anomalies like facial deformities or club feet. The results are in agreement with previous studies that showed a small, but significant increase in the number of cardiac malformations among women who started taking ADHD medication prior to the time of the time of pregnancy. This risk increased during the latter half of pregnancy when many women decided to stop taking their medication.

Women who used adhd medication for adults uk medication in the first trimester of pregnancy were also more likely to have caesarean section, low Apgar score after delivery and a baby who required breathing assistance during birth. However the researchers of the study were not able to eliminate bias due to selection by restricting the study to women who did not have any other medical conditions that could have contributed to the findings.

Researchers hope their research will inform physicians when they meet pregnant women. The researchers recommend that while discussing risks and benefits are important, the choice about whether to continue or stop medication should be made based on the severity of each woman's ADHD symptoms and her needs.

The authors warn that, although stopping the medication is an option to think about, it isn't recommended because of the high incidence of depression and mental health issues in women who are expecting or recently gave birth. Additionally, research suggests that women who stop taking their medications will have a harder time adjusting to a life without them after the baby is born.

Nursing

It can be a stressful experience becoming a mother. Women who suffer from ADHD can face severe challenges when they have to manage their symptoms, go to doctor appointments and prepare for the birth of a baby and adjust to a new routine. Many women opt to continue taking their adhd medication in the uk medication during pregnancy.

The risk to a nursing infant is low because the majority of stimulant medication passes through breast milk in low amounts. The rate of exposure to medication can vary depending upon the dosage the medication is administered, its frequency and time of day. In addition, various drugs enter the infant's system through the gastrointestinal tract or breast milk. The impact of these medications on the health of a newborn is not fully known.

Because of the lack of research, some physicians might be tempted to stop taking stimulant medication during the course of pregnancy. This is a difficult decision for the mother, who must weigh the benefits of her medication against the risk to the foetus. In the meantime, until more information is available, doctors should ask all pregnant patients about their experience with ADHD and if they plan or are taking to take medication during the perinatal period.

A increasing number of studies have proven that the majority of women are able to safely continue to take their ADHD medication during pregnancy and while breastfeeding. As a result, many patients choose to do so and, in consultation with their doctor they have found that the benefits of continuing their current medication outweigh any risks.

Women who suffer from ADHD who are planning to nurse should seek advice from a specialist psychiatrist before becoming pregnant. They should discuss their medication with their prescriber, and the pros and cons for continuing treatment. This includes non-pharmacological strategies. Psychoeducation is also necessary to help pregnant women with ADHD be aware of the symptoms and the underlying disorder. They should also be educated about treatment options and build coping mechanisms. This should be a multidisciplinary approach including obstetricians, GPs and psychiatry. The pregnancy counselling should consist of the discussion of a treatment plan for both the mother as well as the child, monitoring for signs of deterioration and when necessary, making adjustments to the medication regimen.